Tian, Zhanghuan
He, Kaihua
Dong, Jun
Wang, Zhiqiao
Chen, Jiaxing
Yan, Wenlong
Ran, Wei
Funding for this research was provided by:
National Key Clinical Specialty Construction Projec (No. 2011-170)
Article History
Received: 8 October 2025
Accepted: 8 April 2026
First Online: 17 April 2026
Declarations
:
: This study (ethical approval number 2024-302-01) was approved by the Medical Ethics Committee of The First Affiliated Hospital of Chongqing Medical University and registered in the Chinese Clinical Trial Registry ( , ChiCTR2400090031). The research was conducted from October 2024 to March 2025. This study followed the CONSORT guidelines, and all patients provided written informed consent prior to the study, which was carried out in accordance with the Helsinki Declaration. Patients were not compensated for their participation in the experiment.
: Not applicable.
: The authors declare no competing interests.